Professionals 19 results
Capabilities 14 results
Industry
Practice Area
Government Investigations, Enforcement & Compliance
Industry
Experience 2 results
Experience
|July 17, 2020
Molina Healthcare to Acquire Certain Assets of Passport Health Plan
Insights & News 108 results
Government Program Fraud, False Claims Act & Qui Tam Litigation Playbook
|April 17, 2024
|9 Min Read
E.D. Virginia Endorses Broad Interpretation of Anti-Kickback Statute
The U.S. District Court for the Eastern District of Virginia is the latest court to weigh in on the continuing debate surrounding the scope of the Federal Anti-Kickback Statute (AKS) as it applies to patient assistance programs (PAPs). In a lengthy opinion issued in January 2024, the court endorsed the broad interpretation advanced by the government, expressing little sympathy for the legal or policy arguments advanced by the plaintiffs, a coalition of pharmaceutical manufacturers. The coalition has indicated it will appeal the case to the Fourth Circuit.
Government Program Fraud, False Claims Act & Qui Tam Litigation Playbook
|April 8, 2024
|10+ Min Read
2023 DOJ FCA Enforcement: Expectations for Future
On Feb. 22, 2024, the US Department of Justice (DOJ) released its annual False Claims Act (FCA) recovery statistics and announced that it obtained more than $2.68 billion in settlements and judgments in fiscal year (FY) 2023 from civil cases involving fraud and false claims against the government, a 21% increase over the prior year's recoveries. As such, FY 2023 was another strong year for FCA enforcement and marked the fifteenth straight year where recoveries exceeded $2 billion. This past fiscal year also saw records set in several areas, including the highest number of settlements and judgments in DOJ history and a record number of civil investigative demands (CIDs) issued in connection with investigating FCA claims, revealing highly robust FCA investigative activity in 2023, which could signal even greater FCA judgments and recoveries in future years.
Competition Corner
|March 6, 2024
|4 Min Read
U.S. Antitrust Agencies Continue to Target Private Equity Involvement in Healthcare
In the latest step in the U.S. antitrust agencies’ heightened enforcement against private equity, the Federal Trade Commission held a Workshop on Private Equity in Health Care yesterday with the U.S. Department of Justice and Department of Health and Human Services.
Other Results 13 results
Location
Location
Location